⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8691833 | 1.00 | — | — | |
| SCHEMBL2353225 | 0.80 | TDP1 (0.48) | — | |
| SCHEMBL2872011 | 0.79 | — | — | |
| SCHEMBL8691016 | 0.77 | — | — | |
| SCHEMBL8691012 | 0.77 | — | — | |
| SCHEMBL28250562 | 0.77 | ACE2 (0.48) | — | |
| SCHEMBL28774300 | 0.75 | GPR84 (0.50) | — | |
| SCHEMBL9305795 | 0.74 | TDP1 (0.50) | — | |
| SCHEMBL24827776 | 0.72 | — | — | |
| SCHEMBL5371229 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12509609-B2 | Curable resin composition, resin cured film, partition wall and optical element | AGC Inc. (JP) | 2025-12-30 | — | — | US | disclosed |
| US-20240392157-A1 | CURABLE RESIN COMPOSITION, RESIN CURED FILM, PARTITION WALL AND OPTICAL ELEMENT | AGC Inc. (JP) | 2024-11-28 | — | — | US | disclosed |
| CN-118660924-A | Curable resin composition, resin cured film, partition wall, and optical element | ＡＧＣ株式会社 | 2024-09-17 | — | — | CN | disclosed |
| WO-2023149406-A1 | CURABLE RESIN COMPOSITION, RESIN CURED FILM, PARTITION WALL AND OPTICAL ELEMENT | ＡＧＣ株式会社 | 2023-08-10 | — | — | WO | disclosed |
| CN-111704689-B | High-adhesion water-based vinylidene chloride copolymer emulsion for metal surface and preparation method thereof | 天津城建大学 | 2022-04-26 | — | — | CN | disclosed |
| CN-109568166-B | Fragrance materials | 宝洁公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-111704689-A | High-adhesion water-based vinylidene chloride copolymer emulsion for metal surface and preparation method thereof | 天津城建大学 | 2020-09-25 | — | — | CN | disclosed |
| CN-107936166-B | Styrene-butadiene latex and preparation method thereof | 杭州龙驹合成材料有限公司 | 2020-09-22 | — | — | CN | disclosed |
| CN-111518235-A | Water-based vinylidene chloride copolymer resin and preparation method thereof | 天津城建大学 | 2020-08-11 | — | — | CN | disclosed |
| US-20150011597-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | THERAVANCE BIOPHARMA R&D IP, LLC. (US) | 2015-01-08 | — | — | US | disclosed |
| US-20110237703-A1 | PROCESS FOR PRODUCING PHOTOCURABLE MATERIAL, PHOTOCURABLE MATERIAL AND ARTICLE | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-09-29 | — | — | US | disclosed |
| EP-2360195-A1 | PHOTO-CURING MATERIAL MANUFACTURING METHOD, AND PHOTO-CURING MATERIAL AND ARTICLE | Asahi Glass Company Limited (JP) | 2011-08-24 | — | — | EP | disclosed |
| EP-2297113-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | Theravance, Inc. (US) | 2011-03-23 | — | — | EP | disclosed |
| US-20100267788-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | THERAVANCE, INC. (US) | 2010-10-21 | — | — | US | disclosed |
| US-7777077-B2 | 2-Mercaptomethyl-4-methylpentanoic Acid (2-Butyryl-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]aminoethyl)amide | THERAVANCE, INC. (US) | 2010-08-17 | — | — | US | disclosed |
| EP-2132187-A2 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | Theravance, Inc. (US) | 2009-12-16 | — | — | EP | disclosed |
| WO-2009134741-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | THERAVANCE, INC. (US) | 2009-11-05 | — | — | WO | disclosed |
| US-20090270473-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | THERAVANCE BIOPHARMA R&D IP, LLC | 2009-10-29 | — | — | US | disclosed |
| WO-2008097459-A2 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | THERAVANCE, INC. (US) | 2008-08-14 | — | — | WO | disclosed |
| US-20080188533-A1 | 2-Mercaptomethyl-4-methylpentanoic Acid (2-Butyryl-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]aminoethyl)amide | THERAVANCE BIOPHARMA R&D IP, LLC | 2008-08-07 | — | — | US | disclosed |